Given our experience and the enormous volume of patients with pancreatic disease that we see here at Columbia, we felt that it was valuable to formalize our treatment of these patients with a full-service program.

Karim J. Halazun, MD, a hepatobiliary and liver transplant surgeon in the Center for Liver Disease and Transplantation at NYP WCMC, has sought ways to improve and optimize the current liver transplantation allocation system.

Researchers at NewYork-Presbyterian/Columbia University Irving Medical Center have shown that complications stemming from colorectal surgery decreased after introducing a national quality improvement program.

According to researchers at Weill Cornell Medicine, common drug treatments that lead to changes in gut fungi can persistently exacerbate allergic airway diseases such as asthma.

As David L. Carr-Locke, MD, sees it, the identification of a previously unknown anatomical structure in the human body harkens back to the medical discoveries of centuries past.

The primary goal of the study is to see whether adding radiation therapy to an intensive chemotherapy regimen will improve the survival rate of patients with borderline resectable pancreatic cancer.

Education is a major focus of Aaron Schulman, MD, an endocrinologist in the Division of Endocrinology, Diabetes, and Metabolism and Director of the Endocrinology Fellowship Program at NewYork-Presbyterian/Weill Cornell.

Laura C. Alonso, MD, a noted physician-scientist, has been appointed Chief of the Division of Endocrinology, Diabetes and Metabolism at NYP/WCMC and Director of the newly established Joan and Sanford I. Weill Center for Metabolic Health at WCM.